AU2016264102A1 - Compositions and methods for enriching populations of nucleic acids - Google Patents

Compositions and methods for enriching populations of nucleic acids Download PDF

Info

Publication number
AU2016264102A1
AU2016264102A1 AU2016264102A AU2016264102A AU2016264102A1 AU 2016264102 A1 AU2016264102 A1 AU 2016264102A1 AU 2016264102 A AU2016264102 A AU 2016264102A AU 2016264102 A AU2016264102 A AU 2016264102A AU 2016264102 A1 AU2016264102 A1 AU 2016264102A1
Authority
AU
Australia
Prior art keywords
nucleic acids
host
oligonucleotides
sample
nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016264102A
Other languages
English (en)
Inventor
Timothy A. Blauwkamp
Fred Christians
Michael Kertesz
Scott Smith
Igor D. Vilfan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karius Inc
Original Assignee
Karius Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karius Inc filed Critical Karius Inc
Publication of AU2016264102A1 publication Critical patent/AU2016264102A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/155—Modifications characterised by incorporating/generating a new priming site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/161—Modifications characterised by incorporating target specific and non-target specific sites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/159—Reduction of complexity, e.g. amplification of subsets, removing duplicated genomic regions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2016264102A 2015-05-18 2016-05-17 Compositions and methods for enriching populations of nucleic acids Abandoned AU2016264102A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562163273P 2015-05-18 2015-05-18
US62/163,273 2015-05-18
US201662334348P 2016-05-10 2016-05-10
US62/334,348 2016-05-10
PCT/US2016/032936 WO2016187234A1 (en) 2015-05-18 2016-05-17 Compositions and methods for enriching populations of nucleic acids

Publications (1)

Publication Number Publication Date
AU2016264102A1 true AU2016264102A1 (en) 2017-12-21

Family

ID=57320699

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016264102A Abandoned AU2016264102A1 (en) 2015-05-18 2016-05-17 Compositions and methods for enriching populations of nucleic acids

Country Status (10)

Country Link
US (3) US11111520B2 (cg-RX-API-DMAC7.html)
EP (2) EP3298169B1 (cg-RX-API-DMAC7.html)
JP (3) JP6873921B2 (cg-RX-API-DMAC7.html)
CN (1) CN107922971A (cg-RX-API-DMAC7.html)
AU (1) AU2016264102A1 (cg-RX-API-DMAC7.html)
BR (1) BR112017024747A2 (cg-RX-API-DMAC7.html)
CA (1) CA2986036C (cg-RX-API-DMAC7.html)
IL (1) IL255647B (cg-RX-API-DMAC7.html)
WO (1) WO2016187234A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201708264B (cg-RX-API-DMAC7.html)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015364286B2 (en) 2014-12-20 2021-11-04 Arc Bio, Llc Compositions and methods for targeted depletion, enrichment, and partitioning of nucleic acids using CRISPR/Cas system proteins
EP3298169B1 (en) 2015-05-18 2024-10-02 Karius, Inc. Compositions and methods for enriching populations of nucleic acids
EP3985111A1 (en) 2015-08-19 2022-04-20 Arc Bio, LLC Capture of nucleic acids using a nucleic acid-guided nuclease-based system
US11725233B2 (en) 2015-11-16 2023-08-15 Revere Biosensors, Llc Systems and methods for identifying and distinguishing genetic samples
KR102326769B1 (ko) 2016-03-25 2021-11-17 카리우스, 인코포레이티드 합성 핵산 스파이크-인
WO2018119399A1 (en) 2016-12-23 2018-06-28 Grail, Inc. Methods for high efficiency library preparation using double-stranded adapters
GB2559319B (en) * 2016-12-23 2019-01-16 Cs Genetics Ltd Reagents and methods for the analysis of linked nucleic acids
WO2018140452A1 (en) 2017-01-30 2018-08-02 Counsyl, Inc. Enrichment of cell-free dna from a biological sample
CN110352243B (zh) * 2017-03-27 2024-05-28 积水医疗株式会社 使用抗体的靶标核酸浓缩和回收方法
WO2018183918A1 (en) 2017-03-30 2018-10-04 Grail, Inc. Enhanced ligation in sequencing library preparation
US11118222B2 (en) * 2017-03-31 2021-09-14 Grail, Inc. Higher target capture efficiency using probe extension
CA3059370C (en) 2017-04-12 2022-05-10 Karius, Inc. Methods for concurrent analysis of dna and rna in mixed samples
WO2018195951A1 (en) * 2017-04-28 2018-11-01 Coyote Diagnostics Lab (Beijing) Co., Ltd. Integrated sample collection, processing and analysis systems
CA3063106A1 (en) 2017-05-09 2018-11-15 Revere Biosensors, Llc Systems and methods for identifying and distinguishing genetic samples
SG11202003588QA (en) 2017-09-20 2020-05-28 Molecular Stethoscope Inc Methods and systems for detecting tissue conditions
AU2018351163A1 (en) 2017-10-18 2020-05-21 Day Zero Diagnostics, Inc. Selective enrichment of a population of DNA in a mixed DNA sample through targeted suppression of DNA amplification
CN108220479B (zh) * 2018-01-05 2021-08-13 浙江农林大学 能检测多种猪猝死症病原的多重连接探针扩增鉴别试剂盒
CN110272984A (zh) * 2018-03-13 2019-09-24 深圳华大生命科学研究院 测序获取寄生虫核酸信息及对寄生虫分类的方法和系统
WO2019178188A1 (en) * 2018-03-13 2019-09-19 Microinvestigate, Llc Direct-to-consumer genomic diagnostic device
CA3082601A1 (en) 2018-03-16 2019-09-19 Karius, Inc. Sample series to differentiate target nucleic acids from contaminant nucleic acids
CA3067251C (en) 2018-03-19 2024-02-27 Illumina, Inc. Methods and compositions for selective cleavage of nucleic acids with recombinant nucleases
GB201810571D0 (en) * 2018-06-27 2018-08-15 Cs Genetics Ltd Reagents and methods for the analysis of circulating microparticles
WO2020002621A2 (en) 2018-06-29 2020-01-02 F. Hoffmann-La Roche Ag Detection of microsatellite instability
EP3847281A4 (en) * 2018-10-25 2022-04-27 Quadrant Biosciences Inc. METHODS AND MACHINE LEARNING FOR DISEASE DIAGNOSIS
JP7132100B2 (ja) * 2018-11-21 2022-09-06 株式会社日立製作所 生体分子分析装置及び生体分子分析方法
EP4700161A3 (en) 2018-11-21 2026-03-11 Karius, Inc. Direct-to-library methods, systems, and compositions
WO2020106987A1 (en) * 2018-11-21 2020-05-28 Karius, Inc. Detection and prediction of infectious disease
CN109355365A (zh) * 2018-11-25 2019-02-19 中国农业科学院兰州兽医研究所 一种小rna高通量测序检测微生物的方法
CN113039283B (zh) * 2018-12-12 2023-12-26 深圳华大生命科学研究院 分离和/或富集宿主源核酸和病原核酸的方法和试剂及其制备方法
CN113454218A (zh) * 2018-12-20 2021-09-28 夸登特健康公司 用于改进核酸分子的回收的方法、组合物和系统
US12565676B2 (en) 2019-03-01 2026-03-03 Revere Biosensors, Llc Systems and methods for separating decoded arrays
GB201902887D0 (en) * 2019-03-04 2019-04-17 St Georges Hospital Medical School Detection and antibiotic resistance profiling of microorganisms
WO2020198664A1 (en) * 2019-03-28 2020-10-01 The Regents Of The University Of California Methods and systems for sequencing cell-free microbiome dna
EP3953467A4 (en) * 2019-04-08 2023-03-01 Zymo Research Corporation DUPLEX-SPECIFIC NUCLEAR DEPLETION FOR PURIFICATION OF NUCLEIC ACID SAMPLES
SG11202102801TA (en) * 2019-04-29 2021-04-29 Illumina Inc Identification and analysis of microbial samples by rapid incubation and nucleic acid enrichment
US11396679B2 (en) 2019-05-31 2022-07-26 Universal Diagnostics, S.L. Detection of colorectal cancer
WO2021072275A1 (en) 2019-10-11 2021-04-15 Guardant Health, Inc. Use of cell free bacterial nucleic acids for detection of cancer
US11898199B2 (en) 2019-11-11 2024-02-13 Universal Diagnostics, S.A. Detection of colorectal cancer and/or advanced adenomas
CN113631721A (zh) * 2019-12-04 2021-11-09 因美纳有限公司 用于检测血浆中dna病原体的dna测序文库的制备
WO2021122846A1 (en) * 2019-12-16 2021-06-24 Qiagen Gmbh Enrichment method
CN111254190B (zh) * 2020-01-20 2021-02-23 中国医学科学院病原生物学研究所 一种血浆病毒组学的纳米孔三代测序检测方法
WO2021163692A1 (en) * 2020-02-14 2021-08-19 Rhode Island Hospital Rna sequencing to diagnose sepsis
CN111239392B (zh) * 2020-02-26 2023-04-21 浙江诺迦生物科技有限公司 一种新型冠状病毒肺炎(covid-19)血清学诊断试剂盒
JP7522431B2 (ja) * 2020-04-01 2024-07-25 国立大学法人北海道大学 動物試料からのウイルス検出方法
KR20220164745A (ko) * 2020-04-06 2022-12-13 옥탄트, 인크. 병원체 진단 시험
WO2021228418A1 (en) 2020-05-15 2021-11-18 Universal Diagnostics, S.L. Methods and systems for identifying methylation biomarkers
EP4150121A1 (en) * 2020-06-30 2023-03-22 Universal Diagnostics, S.A. Systems and methods for detection of multiple cancer types
WO2022174117A1 (en) * 2021-02-12 2022-08-18 Karius, Inc. Metagenomic next-generation sequencing of microbial cell-free nucleic acids in subjects with lyme disease
US20220315986A1 (en) * 2021-04-01 2022-10-06 Diversity Arrays Technology Pty Limited Processes for enriching desirable elements and uses therefor
CN113201599B (zh) * 2021-06-03 2023-03-31 北京大学人民医院 一种基于PCR和nanopore测序检测脑脊液感染哪些病原体的方法
EP4355875A1 (en) * 2021-06-14 2024-04-24 2seventy bio, Inc. Single stranded rna purification methods
CN113684249B (zh) * 2021-08-25 2024-10-22 广州达安基因股份有限公司 一种rna和dna二代测序文库的构建方法及二代测序盒
JP2025518471A (ja) * 2022-05-03 2025-06-17 リキッド バイオプシー ホルドコ,エルエルシー 無細胞微生物核酸分子を富化するためのシステム及び方法
CN115786547A (zh) * 2022-09-29 2023-03-14 武汉明德生物科技股份有限公司 用于病原微生物检测的引物组、试剂盒及其应用方法
CN115786548A (zh) * 2022-09-29 2023-03-14 武汉明德生物科技股份有限公司 用于病原微生物耐药基因检测的引物组、试剂盒及方法
US12606872B2 (en) 2022-11-16 2026-04-21 Universal Diagnostics, S.A. Methods for stratification and early detection of advanced adenoma and/or colorectal cancer using DNA methylation markers
EP4691490A1 (en) 2023-03-31 2026-02-11 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
EP4698643A1 (en) * 2023-04-18 2026-02-25 Karius, Inc. Sample processing to enrich for select species of nucleic acids
WO2025137492A1 (en) * 2023-12-22 2025-06-26 Siemens Healthcare Diagnostics Inc. Method for enriching pathogen dna and implementation thereof
CN118165982A (zh) * 2024-04-17 2024-06-11 上海麦克林生化科技股份有限公司 Rna快速提取试剂盒及其应用
WO2026107397A1 (en) * 2024-11-14 2026-05-21 Oregon Health & Science University Characterization of the epigenetic landscape in complex fluids

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9220773D0 (en) 1992-10-02 1992-11-18 Mini Agriculture & Fisheries Detection of antigens and nucleic acids
US6759217B2 (en) 1996-03-26 2004-07-06 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
USRE39920E1 (en) 1997-05-30 2007-11-13 Xenomics, Inc. Methods for detection of nucleic acid sequences in urine
US6753137B2 (en) 2001-01-31 2004-06-22 The Chinese University Of Hong Kong Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma
US20050202414A1 (en) 2001-11-15 2005-09-15 The Regents Of The University Of California Apparatus and methods for detecting a microbe in a sample
US7727720B2 (en) * 2002-05-08 2010-06-01 Ravgen, Inc. Methods for detection of genetic disorders
US20040209299A1 (en) 2003-03-07 2004-10-21 Rubicon Genomics, Inc. In vitro DNA immortalization and whole genome amplification using libraries generated from randomly fragmented DNA
EP1647600A3 (en) 2004-09-17 2006-06-28 Affymetrix, Inc. (A US Entity) Methods for identifying biological samples by addition of nucleic acid bar-code tags
CA2597948A1 (en) 2005-02-17 2006-08-24 Istituto Nazionale Per Le Malattie Infettive Irccs Lazzaro Spallanzani Compositions and methods for detecting viral specific nucleic acids in urine
ITRM20050068A1 (it) 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine.
US7914982B2 (en) 2005-02-17 2011-03-29 Trovagene, Inc. Methods for detecting pathogen specific nucleic acids in urine
ITRM20050067A1 (it) 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine.
EP1885877A2 (en) 2005-02-17 2008-02-13 Istituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani" IRCCS Compositions and methods for detecting pathogen specific nucleic acids in urine
US20060292585A1 (en) * 2005-06-24 2006-12-28 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
US8532930B2 (en) 2005-11-26 2013-09-10 Natera, Inc. Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals
EP3260556B1 (en) * 2006-05-31 2019-07-31 Sequenom, Inc. Methods for the extraction of nucleic acid from a sample
WO2009025852A2 (en) 2007-08-22 2009-02-26 Xenomics, Inc. Methods of using mirna for detection of in vivo cell death
WO2009032781A2 (en) * 2007-08-29 2009-03-12 Sequenom, Inc. Methods and compositions for universal size-specific polymerase chain reaction
DE102007041864B4 (de) * 2007-09-04 2012-05-03 Sirs-Lab Gmbh Verfahren zum Nachweis von Bakterien und Pilzen
CA2697640C (en) 2007-09-21 2016-06-21 Katholieke Universiteit Leuven Tools and methods for genetic tests using next generation sequencing
CA2715385A1 (en) 2008-02-12 2009-08-20 Pacific Biosciences Of California, Inc. Compositions and methods for use in analytical reactions
ES2532153T3 (es) * 2008-07-18 2015-03-24 Trovagene, Inc. Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR
WO2011015944A2 (en) 2009-08-06 2011-02-10 Cedars-Sinai Medical Center Use of free dna as an early predictor of severity in acute pancreatitis
LT3241914T (lt) * 2009-11-05 2019-04-25 The Chinese University Of Hong Kong Vaisiaus genomo analizė iš motinos biologinio mėginio
DK2496720T3 (da) 2009-11-06 2020-09-28 Univ Leland Stanford Junior Ikke-invasiv diagnose af transplantatafstødning i organ-transplanterede patienter
US20110257031A1 (en) 2010-02-12 2011-10-20 Life Technologies Corporation Nucleic acid, biomolecule and polymer identifier codes
SG185544A1 (en) 2010-05-14 2012-12-28 Fluidigm Corp Nucleic acid isolation methods
US20120077185A1 (en) 2010-08-06 2012-03-29 Tandem Diagnostics, Inc. Detection of genetic abnormalities and infectious disease
EP2426217A1 (en) 2010-09-03 2012-03-07 Centre National de la Recherche Scientifique (CNRS) Analytical methods for cell free nucleic acids and applications
US20120100549A1 (en) * 2010-10-01 2012-04-26 Ibis Biosciences, Inc. Targeted genome amplification methods
WO2012088348A2 (en) 2010-12-23 2012-06-28 Sequenom, Inc. Fetal genetic variation detection
CN109280713A (zh) 2011-04-01 2019-01-29 澳康姆生物实验室公司 用于检测无细胞的病原体特异性核酸的方法和试剂盒
WO2012159023A2 (en) 2011-05-19 2012-11-22 Virginia Commonwealth University Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction
CN103797486A (zh) 2011-06-06 2014-05-14 皇家飞利浦有限公司 用于组装核酸序列数据的方法
US20130024127A1 (en) 2011-07-19 2013-01-24 John Stuelpnagel Determination of source contributions using binomial probability calculations
GB201115095D0 (en) 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
CA3069089A1 (en) 2011-09-22 2013-03-28 Lineage Biosciences, Inc. Compositions and methods for analyzing heterogeneous samples
EP2764458B1 (en) 2011-10-06 2021-04-07 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2929923T3 (es) 2012-01-20 2022-12-02 Sequenom Inc Procesos de diagnóstico que condicionan las condiciones experimentales
EP3584327A1 (en) 2012-01-27 2019-12-25 The Board of Trustees of the Leland Stanford Junior University Methods for profiling and quantitating cell-free rna
EP4155401A1 (en) * 2012-03-02 2023-03-29 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP2823064B1 (en) * 2012-03-05 2019-02-06 President and Fellows of Harvard College Methods for epigenetic sequencing
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
AU2013232123B2 (en) 2012-03-13 2014-10-30 The Chinese University Of Hong Kong Methods for analyzing massively parallel sequencing data for noninvasive prenatal diagnosis
US10385396B2 (en) 2012-04-19 2019-08-20 The Medical College Of Wisconsin, Inc. Highly sensitive surveillance using detection of cell free DNA
EP2653562A1 (en) 2012-04-20 2013-10-23 Institut Pasteur Anellovirus genome quantification as a biomarker of immune suppression
EP4026912A1 (en) * 2012-05-10 2022-07-13 The General Hospital Corporation Methods for determining a nucleotide sequence
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CN104603289A (zh) 2012-06-15 2015-05-06 哈里·斯泰利 检测疾病或病状的方法
WO2014019275A1 (en) 2012-07-31 2014-02-06 Bgi Shenzhen Co., Limited Noninvasive detection of fetal health status
US10233508B2 (en) * 2012-08-21 2019-03-19 Qiagen Gmbh Virus particle stabilisation and method for isolating viral nucleic acids
US9316802B2 (en) 2012-08-24 2016-04-19 Commscope Technologies Llc Optical fiber cable having reinforcing layer of tape heat-bonded to jacket
US20140066317A1 (en) 2012-09-04 2014-03-06 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
PL2893040T3 (pl) 2012-09-04 2019-05-31 Guardant Health Inc Sposoby wykrywania rzadkich mutacji i wariantu liczby kopii
EP3026124A1 (en) 2012-10-31 2016-06-01 Genesupport SA Non-invasive method for detecting a fetal chromosomal aneuploidy
GB201302900D0 (en) 2013-02-19 2013-04-03 Genome Res Ltd Nucleic acid marker molecules for identifying and detecting cross contaminationof nucleic acid samples
US20140242582A1 (en) 2013-02-28 2014-08-28 Ariosa Diagnostics, Inc. Detection of genetic abnormalities using ligation-based detection and digital pcr
WO2014145078A1 (en) 2013-03-15 2014-09-18 Verinata Health, Inc. Generating cell-free dna libraries directly from blood
US20160032396A1 (en) 2013-03-15 2016-02-04 The Board Of Trustees Of The Leland Stanford Junior University Identification and Use of Circulating Nucleic Acid Tumor Markers
ES2980689T3 (es) 2013-03-15 2024-10-02 Guardant Health Inc Métodos para la secuenciación de polinucleótidos libres de células
US9578045B2 (en) 2013-05-03 2017-02-21 Webroot Inc. Method and apparatus for providing forensic visibility into systems and networks
WO2015048535A1 (en) * 2013-09-27 2015-04-02 Natera, Inc. Prenatal diagnostic resting standards
US20150119260A1 (en) 2013-10-18 2015-04-30 National Taiwan University Circulating cancer biomarker and its use
KR102205950B1 (ko) * 2013-11-07 2021-01-22 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 인간 마이크로바이옴 및 그의 성분의 분석을 위한 무세포 핵산
WO2015085105A1 (en) * 2013-12-04 2015-06-11 University Of Alaska Fairbanks Methods and compositions for enriching non-host sequences in host samples
EP3298169B1 (en) 2015-05-18 2024-10-02 Karius, Inc. Compositions and methods for enriching populations of nucleic acids
KR102326769B1 (ko) 2016-03-25 2021-11-17 카리우스, 인코포레이티드 합성 핵산 스파이크-인
CA3031231A1 (en) 2016-08-08 2018-02-15 Karius, Inc. Reduction of signal from contaminant nucleic acids
WO2018045359A1 (en) 2016-09-02 2018-03-08 Karius, Inc. Detection and treatment of infection during pregnancy
CA3059370C (en) 2017-04-12 2022-05-10 Karius, Inc. Methods for concurrent analysis of dna and rna in mixed samples
CA3082601A1 (en) 2018-03-16 2019-09-19 Karius, Inc. Sample series to differentiate target nucleic acids from contaminant nucleic acids
WO2020106987A1 (en) 2018-11-21 2020-05-28 Karius, Inc. Detection and prediction of infectious disease
EP4700161A3 (en) 2018-11-21 2026-03-11 Karius, Inc. Direct-to-library methods, systems, and compositions
US20220195496A1 (en) 2020-12-17 2022-06-23 Karius, Inc. Sequencing microbial cell-free dna from asymptomatic individuals
EP4263866A4 (en) 2020-12-21 2024-12-04 Karius, Inc. Sequencing microbial cell-free nucleic acids to detect inflammation, secondary infection, and disease severity
WO2022150725A1 (en) 2021-01-11 2022-07-14 Karius, Inc. Rapid, non-invasive detection and serial monitoring of infections in subjects using microbial cell-free dna sequencing
WO2022174117A1 (en) 2021-02-12 2022-08-18 Karius, Inc. Metagenomic next-generation sequencing of microbial cell-free nucleic acids in subjects with lyme disease

Also Published As

Publication number Publication date
CN107922971A (zh) 2018-04-17
EP4450636A2 (en) 2024-10-23
WO2016187234A1 (en) 2016-11-24
EP3298169A1 (en) 2018-03-28
EP4450636A3 (en) 2025-01-01
JP2023110928A (ja) 2023-08-09
JP6873921B2 (ja) 2021-05-19
CA2986036A1 (en) 2016-11-24
ZA201708264B (en) 2022-03-30
BR112017024747A2 (pt) 2018-11-13
EP3298169B1 (en) 2024-10-02
EP3298169A4 (en) 2018-10-24
US12291739B2 (en) 2025-05-06
US20220154246A1 (en) 2022-05-19
US11111520B2 (en) 2021-09-07
JP7769480B2 (ja) 2025-11-13
US20170016048A1 (en) 2017-01-19
JP2018520652A (ja) 2018-08-02
HK1251946A1 (en) 2019-05-03
JP2021112200A (ja) 2021-08-05
IL255647A (en) 2018-01-31
US20260002197A1 (en) 2026-01-01
IL255647B (en) 2022-04-01
CA2986036C (en) 2022-07-26

Similar Documents

Publication Publication Date Title
US12291739B2 (en) Compositions and methods for enriching populations of nucleic acids
US20240344111A1 (en) Sample series to differentiate target nucleic acids from contaminant nucleic acids
JP7300831B2 (ja) ゲノムアセンブリ、ハプロタイプフェージング、および標的に依存しない核酸検出のための方法
CA3014070C (en) Synthetic nucleic acid spike-ins
JP2022095676A (ja) 保存されたサンプルからの長距離連鎖情報の回復
US20180044660A1 (en) METHODS, COMPOSITIONS, AND KITS FOR GENERATING rRNA-DEPLETED SAMPLES OR ISOLATING rRNA FROM SAMPLES
WO2011106536A2 (en) Methods of diagnosing infectious disease pathogens and their drug sensitivity
HK40116790A (en) Compositions and methods for enriching populations of nucleic acids
HK1251946B (en) Compositions and methods for enriching populations of nucleic acids
US20250305029A1 (en) Generation of phased read-sets for genome assembly and haplotype phasing

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application